TABLE 2.
Associations of FADS1 rs174550 with erythrocyte PUFAs
| Beijing |
Shanghai |
Total |
|||||
| Fatty Acid (% wt of total FA) | β (SE) | P | β (SE) | P | β (SE) | P | P for Heterogeneity |
| 18:2n-6 | 0.81 (0.08) | 2.01 × 10−25 | 0.77 (0.08) | 2.70 × 10−24 | 0.79 (0.06) | 5.11 × 10−48 | 0.73 |
| 20:2n-6 | 0.028 (0.002) | 1.91 × 10−32 | 0.026 (0.002) | 3.05 × 10−38 | 0.027 (0.001) | 7.91 × 10−69 | 0.54 |
| 22:2n-6 | 0.004 (0.0007) | 4.36 × 10−9 | 0.005 (0.0006) | 4.66 × 10−16 | 0.005 (0.0005) | 4.77 × 10−23 | 0.31 |
| 18:3n-6 | −0.022 (0.003) | 5.06 × 10−16 | −0.035 (0.002) | 1.70 × 10−49 | −0.029 (0.006) | 2.98 × 10−6 | 0.0007 |
| 20:3n-6 | 0.25 (0.010) | 1.17 × 10−145 | 0.17 (0.009) | 2.08 × 10−82 | 0.21 (0.04) | 8.30 × 10−7 | 8.70 × 10−11 |
| 20:4n-6 | −0.97 (0.06) | 9.66 × 10−59 | −0.87 (0.06) | 8.82 × 10−52 | −0.92 (0.05) | 1.01 × 10−73 | 0.22 |
| 22:4n-6 | −0.21 (0.02) | 2.77 × 10−27 | −0.16 (0.02) | 7.25 × 10−21 | −0.19 (0.03) | 8.97 × 10−11 | 0.03 |
| 22:5n-6 | −0.002 (0.012) | 0.87 | 0.021 (0.012) | 0.07 | 0.010 (0.008) | 0.26 | 0.18 |
| 18:3n-3 | 0.07 (0.02) | 0.0008 | 0.10 (0.02) | 6.04 × 10−7 | 0.08 (0.02) | 3.02 × 10−7 | 0.25 |
| EPA | −0.025 (0.005) | 9.11 × 10−7 | −0.050 (0.007) | 6.58 × 10−11 | −0.04 (0.01) | 0.003 | 0.006 |
| 22:5n-3 | −0.06 (0.01) | 2.70 × 10−8 | −0.07 (0.01) | 1.98 × 10−13 | −0.07 (0.01) | 1.86 × 10−13 | 0.21 |
| DHA | −0.023 (0.03) | 0.45 | 0.002 (0.03) | 0.96 | −0.01 (0.02) | 0.60 | 0.58 |
| 20:4n-6/20:3n-6 | −2.39 (0.08) | 7.73 × 10−189 | −1.98 (0.07) | 2.51 × 10−175 | −2.18 (0.20) | 1.89 × 10−26 | 0.0001 |
18:3n-3 was log-transformed before analyses. βs (SE) are expressed as changes in the levels of PUFA or their ratio for increasing copy of FADS1 rs174550 C-allele in the total population. P values are adjusted for age, sex, BMI, and residence (urban/rural) using an additive model. Random-effect model was used in the meta-analysis.